title: Severe but reversible hepatitis induced by troglitazone.
authors.affiliation: Department of Medicine, University of Chicago Medical Center, Illinois 60637, USA.
authors.forename: T
authors.initials: T
authors.lastname: Schiano
authors.forename: K
authors.initials: K
authors.lastname: Dolehide
authors.forename: J
authors.initials: J
authors.lastname: Hart
authors.forename: A L
authors.initials: AL
authors.lastname: Baker
mesh_terms: D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis* / Q000473:pathology; D002839:Chromans / Q000008:administration & dosage / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects*; D045162:Thiazolidinediones; D000077288:Troglitazone
chemical_list: D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone